AN2 Therapeutics ANTX Cash Flow Statement (2021-2026)

NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

AN2 Therapeutics Quarterly Cash Flow Statement

Periods 23 quarters
Latest Sep 2026

AN2 Therapeutics reported cash from operations of -$6.10M and free cash flow of -$6.10M for the quarter ended Sep 2026, up 4.3% year over year. This cash flow statement covers 23 quarters of results from Mar 2021 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-7.55M-7.66M-10.12M-11.34M-11.84M-15.32M-15.80M-16.71M-16.90M-16.62M-14.44M-12.75M-7.52M-10.65M-6.46M-9.40M-8.67M-10.03M-8.19M-8.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.00M
Share-based CompensationStock Comp.
0.43M0.45M1.24M1.23M1.47M2.07M1.94M2.17M2.23M2.39M2.27M1.90M1.78M2.05M2.00M0.84M1.40M1.46M0.97M0.97M
Other non-cash itemsOther Non-Cash
0.02M0.02M0.02M0.02M0.02M0.02M0.01M
Change in Working Capital
Change in Account PayablesChange Payables
-0.95M1.55M0.44M-0.17M0.68M1.42M-0.41M1.65M-2.11M-0.24M-0.55M-0.17M1.61M-0.24M-0.96M0.11M0.80M-0.41M-1.00M0.05M
Change in Accrued ExpensesChange Accrued Exp.
-0.27M-0.58M1.26M0.01M1.03M-1.43M5.03M0.12M0.12M-3.02M0.85M0.27M-0.43M-1.15M-0.35M-0.25M-0.65M-1.81M0.48M0.45M
Change in Other Operating AssetsOther Assets Change
1.04M0.57M2.08M-0.63M-0.33M-0.74M1.17M-0.02M0.62M-1.11M0.80M0.32M-0.82M-0.65M1.81M-2.51M-0.16M0.27M-0.72M-0.04M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M0.96M-0.31M-0.35M0.24M0.72M-0.48M-0.42M0.35M-0.53M1.22M-0.66M0.21M0.17M
Other Working Capital ChangesOther WC Changes
-1.04M-0.58M-2.10M0.61M0.31M0.72M-1.19M0.98M-0.93M0.76M-0.56M0.40M0.33M0.22M-1.46M1.98M1.38M-0.93M0.93M0.21M
Cash from OperationsCash from Ops.
-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.80M-17.07M-17.60M-14.40M-12.00M-5.26M-10.62M-7.60M-6.38M-5.23M-12.10M-7.00M-6.10M
Investing Activities
Purchase of InvestmentsInvestments Purchased
16.00M1.00M52.99M22.41M17.45M14.01M13.12M85.21M19.83M9.78M24.38M22.31M11.67M3.89M8.33M2.70M13.66M33.44M
Sale and Maturity of InvestmentsInvestments Sold
22.25M14.98M13.50M20.09M23.50M24.90M21.00M22.75M20.25M26.29M29.05M28.50M17.50M31.50M17.50M10.00M15.50M10.99M10.00M9.00M
Cash from Investing ActivitiesCash from Investing
6.25M13.98M-39.49M-2.32M6.06M10.89M7.88M-62.46M0.42M26.29M16.46M18.72M-6.88M9.19M5.83M6.11M7.17M8.29M-3.66M-24.44M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.00M63.20M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M0.24M
Shares Repurchased
0.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.00M63.19M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M0.24M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.00M63.19M7.18M-0.01M0.20M19.05M0.27M0.35M0.02M0.07M0.05M0.06M0.05M0.24M
Other financing activities (as filed)
-0.97M
Cash from Financing ActivitiesCash from Financing
-0.97M63.19M7.18M-0.01M0.20M19.05M66.07M-0.32M0.35M0.02M0.07M0.05M37.33M1.49M6.43M
Additional items
Change in Cash
-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.20M-16.97M9.05M2.08M6.74M-12.15M-1.37M-1.77M-0.22M1.94M33.55M-9.17M-24.11M
Ending Cash Balance
12.10M82.52M40.62M28.80M27.22M26.71M40.81M32.62M15.65M24.69M26.77M33.50M21.35M19.99M18.22M18.00M19.94M53.49M44.32M20.21M
Free Cash FlowFCF
-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.80M-17.07M-17.60M-14.40M-12.00M-5.26M-10.62M-7.60M-6.38M-5.23M-12.10M-7.00M-6.10M
Net Cash FlowNCF
-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.20M-16.97M9.04M2.06M6.74M-12.14M-1.37M-1.77M-0.22M1.94M33.52M-9.17M-24.11M

AN2 Therapeutics Cash Flow Statement API

Pull AN2 Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY